Tag Archives: Biogen

U.S. regulators on Monday approved Biogen Inc’s aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease despite controversy over whether the clinical evidence proves the drug works. Aducanumab aims to remove sticky deposits of a protein called amyloid-beta from the brains of patients in earlier stages …

A US drug company says it has created the first therapy that could slow Alzheimer’s disease, and it is now ready to bring it to market. Currently, there are no drugs that can do this – existing ones only help with symptoms. Biogen says it will soon seek regulatory approval …